HeyJaredRMD Open
- Indexed articles, last 90 days
- 9
- Latest publication
- Sep 9, 2026
- Outlet visibility, for Medscape
- Top 50K sites
- Earliest in this view
- Jul 17, 2026
Latest articles
Inflammation on Imaging May Help Predict Hand OA Progression (opens the original)
Read excerpt
Patients with hand osteoarthritis (OA) who had synovitis on baseline ultrasonography or MRI had increased odds of radiographic worsening in the first carpometacarpal (CMC1) joint at the thumb base and interphalangeal joints. "[The] findings support inflammation as a relevant mechanism across hand OA phenotypes," the authors of the study wrote. The study was led by Lovisa Klingenberg of Diakonhjemmet Hospital in Oslo, Norway. It was published online on August 20, 2026, in RMD Open. The study lack
Upadacitinib Effective in PsA After TNF Inhibitor Failure (opens the original)
Read excerpt
Upadacitinib 15 mg once daily was associated with effective disease control in patients with psoriatic arthritis (PsA) who had previously received one TNF inhibitor. Early pain levels predicted long-term minimal disease activity (MDA) achievement. "[The] analysis suggests that upadacitinib could be an effective therapeutic alternative to TNF inhibitor cycling for those who have failed one TNF inhibitor therapy, although further research is needed to confirm this," the authors wrote. The study wa
Antiphospholipid Antibodies Linked to Pregnancy Risks in SLE (opens the original)
Read excerpt
Women with systemic lupus erythematosus (SLE) who tested positive for antiphospholipid antibodies (aPLs) were more likely to experience adverse pregnancy outcomes than those without these antibodies. "The findings of this study highlight the importance of risk stratification and individualized management among patients with SLE who are positive for aPLs, putting more focus on those with LA [lupus anticoagulant] plus IgG isotypes of aCL and/or anti-β2GPI antibodies, to achieve favorable pregnancy
IL-6 Receptor Inhibitors Beat Conventional Therapy in PMR (opens the original)
Read excerpt
Patients with steroid-refractory polymyalgia rheumatica (PMR) initiating interleukin 6 receptor inhibitor (IL-6Ri) therapy were more likely to discontinue glucocorticoids and achieve minimal glucocorticoid use by year 1 compared with those receiving conventional synthetic immunomodulatory (csIM) therapy or methotrexate alone. IL-6Ri therapy demonstrated a safety profile consistent with previous studies. "In this real world study, IL-6Ri therapy was more effective than csIM therapy (overall and M
Diffuse Axial Pain Linked to Peripheral Arthritis (opens the original)
Read excerpt
Patients with axial spondyloarthritis (axSpA) who presented with diffuse initial axial involvement, affecting both cervicothoracic and lumbosacral regions, faced more than 60% higher risk for developing peripheral arthritis over 10 years compared with those whose initial pain was confined to the lumbosacral region, a study shows. "Our findings suggest that the initial distribution of inflammatory axial pain may carry prognostic value, particularly for identifying patients at increased risk of pe
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Medscape, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.